Rhodes Pharmaceuticals, L.P. recalls Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmace…
- Recall date
- April 17, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0710-2018
- FDA classification
- Class III
- Brand / firm
- Rhodes Pharmaceuticals, L.P.
- Sold / distributed
- Nationwide within the USA
Why it was recalled
Failed Dissolution Specification: Low dissolution outside of specifications
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45
Get recall alerts
Free email alert whenever Rhodes Pharmaceuticals, L.P. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Rhodes Pharmaceuticals, L.P.